• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩洛哥 2020-2029 年国家癌症控制计划视角下的人乳头瘤病毒疫苗接种。

Human papillomavirus vaccination in view of the National Cancer Control Plan 2020-2029 in Morocco.

机构信息

Reference Center for Reproductive Health, Regional Hospital Center, Kenitra, Morocco.

Plant, Animal and Agro-industry Production Laboratory, Biology Department, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.

出版信息

Pan Afr Med J. 2023 Jul 4;45:115. doi: 10.11604/pamj.2023.45.115.40004. eCollection 2023.

DOI:10.11604/pamj.2023.45.115.40004
PMID:37745922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10516758/
Abstract

In Morocco, cervical cancer represents a major public health problem. It ranks second, after breast cancer in Moroccan women, in terms of incidence and mortality. Each year, more than 3,300 new cases and nearly 2,500 deaths are recorded. A Moroccan national program to fight against cervical cancer (CC) based on the practice of visual inspection after application of acetic acid was set up in 2010, allowing screening and possibly of immediate treatment of premalignant lesions of the cervix. In September 2022, a partnership circular between the Ministry of Health and Social Protection (MSPS) and the Ministry of National Education, Preschool and Sports was launched. it announces that the MSPS will integrate the HPV vaccine using the quadrivalent vaccine into the Moroccan National Immune Program (PNI), the vaccination will be aimed to 11-year-old girls, mainly those in school, who will receive two doses separated by at least a period of 6 months.

摘要

在摩洛哥,宫颈癌是一个主要的公共卫生问题。它在摩洛哥女性中的发病率和死亡率方面排名第二,仅次于乳腺癌。每年,有超过 3300 例新病例和近 2500 例死亡。摩洛哥于 2010 年建立了一个基于醋酸应用后肉眼观察的宫颈癌防治国家方案,以筛查和可能对宫颈癌前病变进行即时治疗。2022 年 9 月,卫生部和社会保护部(MSPS)与教育部、学前和体育部之间发布了一份伙伴关系通告,宣布 MSPS 将在摩洛哥国家免疫计划(PNI)中纳入使用四价疫苗的 HPV 疫苗,接种对象将是 11 岁的女孩,主要是在校女孩,她们将接种两剂疫苗,至少间隔 6 个月。

相似文献

1
Human papillomavirus vaccination in view of the National Cancer Control Plan 2020-2029 in Morocco.摩洛哥 2020-2029 年国家癌症控制计划视角下的人乳头瘤病毒疫苗接种。
Pan Afr Med J. 2023 Jul 4;45:115. doi: 10.11604/pamj.2023.45.115.40004. eCollection 2023.
2
[Cervical cancer: Current situation and management in Morocco].[宫颈癌:摩洛哥的现状与管理]
Bull Cancer. 2019 Nov;106(11):1008-1022. doi: 10.1016/j.bulcan.2019.08.020. Epub 2019 Oct 9.
3
Cervical cancer and HPV: Awareness and vaccine acceptability among parents in Morocco.宫颈癌和 HPV:摩洛哥父母的认知和疫苗接受度。
Vaccine. 2014 Jan 9;32(3):409-16. doi: 10.1016/j.vaccine.2013.10.069. Epub 2013 Nov 1.
4
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).四价人乳头瘤病毒疫苗:免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.
5
Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.在宫颈癌发病率高和筛查覆盖率低的情况下,HPV 疫苗接种的成本效益。
Vaccine. 2017 Nov 1;35(46):6329-6335. doi: 10.1016/j.vaccine.2017.08.083. Epub 2017 Sep 9.
6
Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.摩洛哥女大学生对人乳头瘤病毒(HPV)疫苗的认知、态度和可接受性
PLoS One. 2022 Apr 8;17(4):e0266081. doi: 10.1371/journal.pone.0266081. eCollection 2022.
7
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.实现世界卫生组织宫颈癌消除目标的死亡率影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):591-603. doi: 10.1016/S0140-6736(20)30157-4. Epub 2020 Jan 30.
8
Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.估计人乳头瘤病毒疫苗接种对宫颈癌病例和死亡人数的潜在总体影响。
Vaccine. 2014 Feb 3;32(6):733-9. doi: 10.1016/j.vaccine.2013.11.049. Epub 2013 Nov 26.
9
Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis.摩洛哥的宫颈癌预防:基于模型的成本效益分析。
J Med Econ. 2019 Nov;22(11):1153-1159. doi: 10.1080/13696998.2019.1624556. Epub 2019 Jun 17.
10
Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.在日本,九价 HPV 疫苗对女童和妇女进行常规和补种接种的公共卫生影响和成本效益:基于模型的研究。
BMC Infect Dis. 2021 Jan 6;21(1):11. doi: 10.1186/s12879-020-05632-0.

引用本文的文献

1
Harnessing primary healthcare to reduce the burden of cervical cancer in the Eastern Mediterranean Region.利用初级卫生保健减轻东地中海区域宫颈癌负担。
BMJ Glob Health. 2025 Jun 8;10(6):e017622. doi: 10.1136/bmjgh-2024-017622.

本文引用的文献

1
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.HPV 疫苗接种在全球范围内的推广情况以及世卫组织和儿基会对 2010-2019 年各国 HPV 免疫接种覆盖率的估计。
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
2
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?澳大利亚 HPV 疫苗接种 10 年的影响:九价疫苗将预防哪些额外的疾病负担?
Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700737.
3
Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population.Xpert HPV检测法在阴道镜转诊人群中检测高危型人乳头瘤病毒DNA的可靠性
Am J Clin Pathol. 2015 Jan;143(1):126-33. doi: 10.1309/AJCP4Q0NSDHWIZGU.
4
Cervical cancer screening: from the Papanicolaou smear to the vaccine era.宫颈癌筛查:从巴氏涂片到疫苗时代
J Clin Oncol. 2003 May 15;21(10 Suppl):224s-230s. doi: 10.1200/JCO.2003.01.116.